Credit Rating

Rainbow® Children's ~ BirthRighf Hospital ~ - BY RAINBOW HOSPITALS WOMEN CARE I CHILD CARE I FERTILITY September 29, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Plot No. C/1, Block G, Corporate Relationship Department, Bandra Kurla Complex, Bandra (E), Phiroze Jeejeebhoy Towers, Mumbai – 400 051. Dalal Street, Mumbai – 400001. Symbol: RAINBOW Scrip Code: 543524 Sub: Intimation of credit rating under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/ Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), read with Schedule III thereto and the SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026 (“SEBI Master Circular”), we wish to inform you that ICRA Limited (“ICRA”), has reaffirmed the ratings to the Company’s instrument(s), as detailed below: Name of the Agency Rating Action Remarks ICRA Limited [ICRA] AA (Stable); Reaffirmation of the same rating reaffirmed as assigned last time. This is for your information and record. Thanking You, Yours Faithfully, For Rainbow Children’s Medicare Limited Shreya Mitra Company Secretary & Compliance Officer Encl: As above Rainbow Children's Medicare Limited Registered Office: 8-2-120/103/1, Survey No. 403, Road No. 2, Banjara Hills, Hyderabad- 500034, Telangana CIN :L85110TG 1998PLC029914 Q Corporate Office: 8-2-19/1/A, Daulet Arcade, Road No. 11, Banjara Hills, Hyderabad- 500034, Telangana G info@rainbowhospitals.in \;' 1800 2122 iffil www. rainbowhospitals.in OUR PRESENCE: BENGALURU CHENNAI DELHI GUWAHATI HYDERABAD RAJAHMUNDRY VIJAYAWADA VISAKHAPATNAM WARANGAL ICRA Insights that empower ICRA/Rainbow Children's Medicare Limited /29092026/2 Date: September 29, 2026 Mr. Sudarshan Patodia Chief Financial Officer Rainbow Children's Medicare Limited 8-2-61/1/A, Daulet Arcade, Road No.11, Banjara Hills, Hyderabad 500 034 Dear Sir, Re: ICRA's Credit Rating for below mentioned Instruments of Rainbow Children's Medicare Limited As per the Rating Agreement/Statement of Work executed with ICRA Limited, ICRA's Rating Committee has taken the following rating actions for the mentioned instruments of your company. Rated Amount Financial Sector Instrument Rating Action1 (Rs. crore) Regulator# Issuer Rating - [ICRA]AA(Stable); reaffirmed _$ Total - #SEBl's grievance redressal/dispute resolution and SEBI investor protection mechanisms such as SCORES and ODR shall not be ova ilable for activities and instruments which fall under the regulatory purview of Financial Sector Regulators other than SEBI. $Since no instrument is being rated, FSR is not applicable. The rating scale and definitions stipulated in SEBI Master Circular for CRAs are being followed. The aforesaid rating(s) will become due for surveillance within one year from the date of rating communication letter. However, ICRA reserves the right to review and/or, revise the above rating(s) at any time based on new information becoming available, orthe required information not being available, or other circumstances that ICRA believes could have an impact on the rating(s). Therefore, request the lenders and investors to visit ICRAwebsiteatwww.icra.infor latest rating(s) of the company. The rating(s) arespecific to the terms and conditions of the instruments as indicated to us by you, and any change in the terms or size of the same would require a review of the rating(s) by us. In case there is any change in the terms and conditions or the size of the rated instrument, the same must be brought to our notice before the instrument is used by you. In the event such changes occur after the rating(s) have been assigned by us and their use has been confirmed by you, the rating(s) would be subject to our review,following which there could be a change in the rating(s) previously assigned. Notwithstanding the foregoing, any change in the over-all limit of the instrument from that specified in this letter, would constitute an enhancement that would not be covered by or under the said Rating Agreement. The rating(s) assigned must be understood solely as an opinion and should not be treated, or cause to be treated, as recommendation to buy, sell, or hold the rated instrument availed/issued by your company. 1Complete definitions of the ratings assigned are available at www.icra.in. ICRA Limited Registered Office: B-710, Statesman House, 148, Barakhamba Road, New Delhi 110001. Tel. +91-11-23357940-41 Building No. 8, 2nd floor, Tower A, DLF Cyber City, Phase II, Gurugram-122002 www.icra.in info@icraindia.com +91-93547-38909 +0124-44554455330000 CCIINN:: LL7744999999DDLL11999911PPLLCC004422774499 Sensitivity Label : Restricted ICRA Insights that empower You are also requested to forthwith inform us about any default or delay in repayment of interest or principal amount of the instrument rated, as above, or any other debt instruments/ borrowing and keep us informed of any other developments which may have a direct or indirect impact on the debt servicing capability of the company including any proposal for re-schedulementor postponement of the repayment programmes of the dues/ debts of the company with any lender(s) / investor(s), or occurrence of any significant development that could impact the ability of the company to raise funds such as restriction imposed by any authority from raising funds through issuance of debt securities through electronic bidding system. Further, you are requested to inform us immediately as and when the borrowing limit for the instrument rated, as above, or as prescribed by the regulatory authority(ies) is exceeded. We look forward to your communication and assure you of our best services. With kind regards, Yours sincerely, For ICRA Limited Digitally signed by Sri Kumar Sri Kumar Krishnamurthy Krishnamurthy Date: 2026.09.29 16:31 :54 +05'30' Srikumar Krishnamurthy Senior Vice Presidentand Co-Group Head ksrikumar@icraindia.com Sensitivity Label : Restricted